Serum exocrine pancreas enzymes are biomarkers of immunotherapy response in new-onset type 1 diabetes by Brittany Sorensen Bruggeman, Savanna Gornisiewicz, Rhonda Bacher, Kieran McGrail, Martha Campbell-Thompson, Clive Wasserfall, Laura M. Jacobsen, Laura M. Jacobsen, Mark Atkinson, Michael J. Haller, Desmond A. Schatz

Get full text

Type 1 diabetes prevention clinical trial simulator: Case reports of model‐informed drug development tool by Juan Francisco Morales, Marian Klose, Yannick Hoffert, Jagdeep T. Podichetty, Jackson Burton, Stephan Schmidt, Klaus Romero, Inish O'Doherty, Frank Martin, Martha Campbell‐Thompson, Michael J. Haller, Mark A. Atkinson, Sarah Kim

Get full text

Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagn... by Simon Bond, David Dunger, Mark Wilson, Adrian Mander, Mikael Knip, Anita Chhabra, M Loredana Marcovecchio, Charlotte S Wilhelm-Benartzi, Michael J Haller, Timothy Tree, Hilde Morobé, Sarah E Miller, Sylvaine Bruggraber, Diane Picton, Katrina Gatley, A Emile J Hendriks, Bärbel Aschemeier-Fuchs, Lut Overbergh, Jaivier Pall, Olivier Arnaud, Almut Nitsche, Anke M Schulte

Get full text

Peer Mentoring Improves Diabetes Technology Use and Reduces Diabetes Distress Among Underserved Communities: Outcomes of a Pilot Diabetes Support Coach Intervention by Jennifer Maizel, Michael J. Haller, David M. Maahs, Ananta Addala, Stephanie L. Filipp, Rayhan A. Lal, Matthew J. Gurka, Lauren Figg, Melanie Hechavarria, Dessi P. Zaharieva, Keilecia G. Malden, Sarah Westen, Brittney N. Dixon, Korey Hood, Eleni Sheehan, Jessie J. Wong, William T. Donahoo, Marina Basina, Angelina Bernier, Eliana Frank, Ashby F. Walker

Get full text